RE:Question IMHO
1. We get a decent Share Price Bump the day we hit 90.
2. 30-60 days for Baxter to Review Data and while this is going on the Share Price has a continued gradual appreciation during the review. We shouldn't $1.00 or more...
3. Baxter obviously will move ahead with the Distribution Agreement with a Milestone Payment OR just decide to BUY it all and tie it all together with their Vantive IPO in the Spring or early Summer. BOOM! Share Price should have a Major Move at this point... March - April time frame.
4. Upon FDA Approval whether it happens before or at 150 Patients we have a Hyper Extended Share Price Run that is usually way beyond actual value before it comes back to earth and settles at Industry Standard PE Values for this Medical Sector of the market.
Will be very diligently watching for the Hyper Extended Days to Sell for massive gains.... but not all as nobody knows how high we can go!
I have personally witnessed many many stocks do these type of Massive Moves like for example TPST in October or ADTX in September. We would need to be on the Nasdaq (Vantive?) to experience it on our Holdings here.
All IMHO of course.
Looking Up!
Rev